Acta Neuropathologica

, Volume 76, Issue 3, pp 245–252 | Cite as

Does the pleomorphic xanthoastrocytoma exist?

Problems in the application of immunological techniques to the classification of brain tumors
  • W. Paulus
  • J. Peiffer
Regular Papers

Summary

A case of a fibrous xanthomatous tumor of the meninges is reported. This is a rare tumor of childhood in which the characteristic pleomorphic histology contrasts with the good clinical prognosis [26]. These tumors were reclassified as pleomorphic xanthoastrocytomas (PXA) due to their glial fibrillary acidic protein (GFAP) positivity [27]. In the present tumor, GFAP was absent from nearly all cell bodies in most of the leptomeningeal regions of the tumor but could be detected with greater frequency at the cortical-leptomeningeal border zones and in the areas in which the tumor had infiltrated the cortex. All the tumor cells expressed vimentin and in, addition, most expressed α-1-antitrypsin, α-1-antichymotrypsin, tartrate-resistant acid phosphatase, common leukocyte antigen, and OKM1. This spectrum of marker staining corresponded not only to the pattern observed in two cutaneous fibrous histiocytomas and one malignant fibrous histiocytoma, but also to the results previously published in the literature with regard to fibrohistiocytic tumors. By contrast, this spectrum of monocytic-histiocytic marker staining was not seen in gliomas. We, therefore, regard the PXA as a mesenchymal tumor of the meninges, identical to benign fibrous histiocytomas elsewhere in the body. The possible reasons why this mesenchymal tumor can show GFAP positivity in the leptomeningeal border zone are discussed.

Key words

Pleomorphic xanthoastrocytoma Fibrous xanthoma of the meninges Fibrous histocytoma Glial fibrillary acidic protein Immunohistochemistry 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Allegranza A, Migliavacca F, Mariani C (1980) Xanthoastrocitoma pleomorfocerebromeningeo. Istocitopatologia 2:137–141Google Scholar
  2. 2.
    Beham A, Wirnsberger G, Schmid C, Helleis G (1985) Immunzytochemische Studie an malignen fibrösen Histozytomen. Verh Dtsch Ges Pathol 69:634Google Scholar
  3. 3.
    Boulay CEH du (1982) Demonstration of α-1-antitrypsin and α-1-antichymotrypsin in fibrous histiocytomas using the immunoperoxidase technique. Am J Surg Pathol 6:559–564Google Scholar
  4. 4.
    Brooks J (1982) Immunohistochemistry of soft tissue tumors: myoglobin as a tumor marker for rhabdomyosarcoma. Cancer 50:1757–1763Google Scholar
  5. 5.
    Brooks J (1982) Immunohistochemistry of soft tissue tumors: progress and prospects. Hum Pathol 13:969–974Google Scholar
  6. 6.
    Budka H (1986) Non-glial specificities of immunocytochemistry for the glial fibrillary acidic protein (GFAP). Acta Neuropathol (Berl) 72:43–54Google Scholar
  7. 7.
    Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labelling of monoclonal antialkaline phosphatase. J Histochem Cytochem 32:219–229Google Scholar
  8. 8.
    Deck JHN, Rubinstein LJ (1981) Glial fibrillary acidic protein in stromal cells of some capillary hemangioblastomas: significance and possible implications of an immunoperoxidase study. Acta Neuropathol (Berl) 54:173–181Google Scholar
  9. 9.
    Deck JHN, Eng LF, Bigbee J, Woodcock SM (1978) The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumors. Acta Neuropathol (Berl) 42:183–190Google Scholar
  10. 10.
    Elmer K, Roggendorf W, Peiffer J (1988) Immunocytochemical characterization of human primary tumours and correlation with their proliferative potential. Acta Neuropathol (submitted)Google Scholar
  11. 11.
    Funakoshi T, Yamada H, Miwa Y, Takada M, Okuma A, Shimokawa K, Ikeda T, Ushimaru Y (1984) A case of intracranial multiple fibrous histiocytoma. No Shinkei Geka 12:641–648Google Scholar
  12. 12.
    Gard AL, White FP, Dutton GR (1985) Extra-neural glial fibrillary acidic protein (GFAP) immunoreactivity in perisinusoidal stellate cells of rat liver. J Neuroimmunol 8:359–375Google Scholar
  13. 13.
    Gomez JG, Garcia JH, Colon LE (1985) A variant of cerebral glioma called pleomorphic xanthoastrocytoma: case reprot. Neurosurgery 16:703–706Google Scholar
  14. 14.
    Gonzalez-Vitale JC, Slavin RE, McQueen JD (1976) Radiation-induced intracranial malignant fibrous histiocytoma. Cancer 37:2960–2963Google Scholar
  15. 15.
    Grant JW, Gallagher PJ (1986) Pleomorphic xanthoastrocytoma. Immunohistochemical methods for differentiation from fibrous histiocytomas with similar morphology. Am J Surg Pathol 10:336–341Google Scholar
  16. 16.
    Herpers MJHM, Budka H, McCormick D (1984) Production of glial fibrillary acidic protein (GFAP) by neoplastic cells: adaption to the microenvironment: Acta Neuropathol (Berl) 64:333–338Google Scholar
  17. 17.
    Heyerdahl Strøm E, Skullerud K (1983) Pleomorphic xanthoastrocytoma: report of 5 cases. Clin Neuropathol 2:188–191Google Scholar
  18. 18.
    Hsu SM, Soban E (1982) Colour modification of diaminobenzidine (DAB) precipitation by metallic ions and its application to double immunohistochemistry. J Histochem Cytochem 30:1079–1082Google Scholar
  19. 19.
    Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques — a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577–580Google Scholar
  20. 20.
    Iwaki T, Fukui M, Kondo A, Matsushima T, Takeshita I (1987) Epithelial properties of pleomorphic xanthoastrocytomas determined in ultrastructural and immunohistochemical studies. Acta Neuropathol (Berl) 74: 142–150Google Scholar
  21. 21.
    Iwasaki H, Kikuchi M, Taki M, Enjoji M (1982) Benign and malignant fibrous histiocytomas of the soft tissues. Functional characterization of cultured cells. Cancer 50:520–530Google Scholar
  22. 22.
    Jessen KR, Thorpe R, Mirsky R (1984) Molecular identity, distribution and heterogeneity of glial fibrillary acidic protein; an immunoblotting and immunohistochemical study of Schwann cells, satellite cells, enteric glia and astrocytes. J Neurocytol 13:187–200Google Scholar
  23. 23.
    Jones MC, Drut R, Raglia G (1983) Pleomorphic xanthoastrocytoma: a report of two cases. Pediatr Pathol 1:459–467Google Scholar
  24. 24.
    Kalyanaraman UP, Taraska JJ, Fierer JA, Elwood PW (1981) Malignant fibrous histiocytoma of the meninges. J Neurosurg 55:957–962Google Scholar
  25. 25.
    Kepes JJ (1979) “Xanthomatous” lesions of the central nervous system: definition, classification and some recent observations. In: Zimmerman HM (ed) Progress in neuropathology, vol 4. Raven Press, New York, pp 179–213Google Scholar
  26. 26.
    Kepes JJ, Kepes M, Slowik F (1973) Fibrous xanthomas and xanthosarcomas of the meninges and the brain. Acta Neuropathol (Berl) 23:187–199Google Scholar
  27. 27.
    Kepes JJ, Rubinstein LJ, Eng LF (1979) Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relative favorable prognosis. Cancer 44:1839–1852Google Scholar
  28. 28.
    Kepes JJ, Rubinstein LJ, Chiang H (1984) The role of astrocytes in the formation of cartilage in gliomas: an immunohistochemical study of four cases. Am J Pathol 117:471–483Google Scholar
  29. 29.
    Kindblom LG, Jacobsen GK, Jacobsen M (1982) Immunohistochemical investigations of tumors of supposed fibroblastic-histiocytic origin. Hum Pathol 13:834–840Google Scholar
  30. 30.
    Kirchner T, Wünsch PH, Ormanns W (1984) Zur klinischen Pathologie maligner fibröser Histiozytome des Weichgewebes. Verh Dtsch Ges Pathol 68:413Google Scholar
  31. 31.
    Kleinhues P, Kiessling M, Janzer RC (1987) Morphological markers in neuro-oncology. In: Seifert G (ed) Morphological tumor markers. Springer, Berlin Heidelberg New York, pp 307–338Google Scholar
  32. 32.
    Kuhajda FP, Mendelsohn G, Taxy JB, Long DM (1981) Pleomorphix xanthoastrocytoma: report of a case with light and electron microscopy. Ultrastruct Pathol 2:25–32Google Scholar
  33. 33.
    Kusaka H, Hirano A, Bornstein MB, Moore GRW, Raine CS (1986) Transformation of cells of astrocyte lineage into macrophage-like cells in organotypic cultures of mouse spinal cord tissue. J Neurol Sci 72:77–89Google Scholar
  34. 34.
    Lam RMY, Colah SA (1979) Atypical fibrous histiocytoma with myxoid stroma. Cancer 43:237–245Google Scholar
  35. 35.
    Leder LD, Stutte HJ (1975) Seminar for hämatologischcytochemische Techniken. Verh Dtsch Ges Pathol 59:503–509Google Scholar
  36. 36.
    Maleki M, Robitaille Y, Bertrand G (1983) Atypical xanthoastrocytoma presenting as a meningioma. Surg Neurol 20:235–238Google Scholar
  37. 37.
    Mason DY, Sammons RE (1978) Alkaline phosphate and peroxidase for double immunoenzymatic labelling of cellular constituents. J Clin Pathol 31:454–462Google Scholar
  38. 38.
    Meister P, Nathrath W, Konrad E, Permanetter W (1980) Immunhistochemische Markierung histiozytärer Tumorzellen. Verh Dtsch Ges Pathol 64:441Google Scholar
  39. 39.
    Moore GRW, Raine CS (1986) Leptomeningeal and adventitial gliosis as a consequence of chronic inflammation. Neuropathol Appl Neurobiol 12:371–378Google Scholar
  40. 40.
    Müller H, Iwasaki H, Stutte HJ (1984) Immunhistochemische, enzymhistochemische und ultrastrukturelle Untersuchungen am malignen fibrösen Histiozytom. Verh Dtsch Ges Pathol 68:371Google Scholar
  41. 41.
    Otto HF, Berndt R, Schwechheimer K, Möller P (1987) Mesenchymal tumor markers: Special proteins and enzymes. In: Seifert G (ed) Morphological tumor markers. Springer, Berlin Heidelberg New York, p 179–205Google Scholar
  42. 42.
    Palma L, Maleci A, Di Lorenzo N, Lauro GM (1985) Pleomorphic xanthoastrocytoma with 18-year survival. J Neurosurg 63:808–810Google Scholar
  43. 43.
    Pasquier B, Kojder I, Labat F, Keddari E, Pasquier D, Stoebner P, Barge M, Delpeck B, Couderc P (1985) Le xanthoastrocytome du sujet jeune. Ann Pathol 5:29–43Google Scholar
  44. 44.
    Perentes E, Rubinstein LJ (1987) Recent applications of immunoperoxidase histochemistry in human neuro-oncology. Arch Pathol Lab Med 111:796–812Google Scholar
  45. 45.
    Raine CS, Wisniewski H (1970) On the occurrence of microtubules within mature astrocytes. Anat Rec 167:303–308Google Scholar
  46. 46.
    Roholl PJM, Kleyne J, Elbers H, van der Vegt MCD, Albus-Lutter C, van Unnik JAM (1985) Characterization of tumour cells in malignant fibrous histiocytomas and other soft tissue tumours in comparison with malignant histiocytes. J Pathol 147:87–95Google Scholar
  47. 47.
    Rubinstein LJ (1986) Immunohistochemical signposts —not markers — in neural tumour differentiation. Neuropathol Appl Neurobiol 12:523–537Google Scholar
  48. 48.
    Sakai H, Kawano N, Okado K, Tanabe T, Yada K, Yagishita S (1981) A case of pleomorphic xanthoastrocytoma (Kepes). No Shinkei Geka 9:1519–1524Google Scholar
  49. 49.
    Schiffer D, Giordana MT, Mauro A, Migheli A, Germano I, Giaccone G (1986) Immunohistochemical demonstration of vimentin in human cerebral tumors. Acta Neuropathol (Berl) 70:209–219Google Scholar
  50. 50.
    Schindler E, Gulotta F (1983) Glial fibrillary acidic protein in medulloblastomas and other embryonic CNS tumours of children. Virchows Arch [A] 398:263–275Google Scholar
  51. 51.
    Simpson RHW, Phillips JI, Miller P, Hagen P, Anderson JEM (1986) Intracerebral malignant fibrous histiocytoma: a light and electron microscopic study with immunohistochemistry. Clin Neuropathol 5:185–189Google Scholar
  52. 52.
    Sternberger LA, Hardy PH, Cuculis JJ, Meyer HG (1969) The unlabeled antibody enzyme method of immunohistochemistry. J Histochem Cytochem 18:315–333Google Scholar
  53. 53.
    Taratuto AL, Monges J, Lylyk P, Leiguarda R (1984) Superficial cerebral astrocytoma attached to dura. Cancer 54:2505–2512Google Scholar
  54. 54.
    Terashima K, Aoyama K, Nihei K, Nito T, Imai Y, Takahashi K, Daidoji S (1983) Malignant fibrous histiocytoma of the heart. Cancer 52:1919–1926Google Scholar
  55. 55.
    Tsao MS, Becker L, Finlayson M (1983) Giant cell astrocytoma with histiocytic infiltrate. Acta Neuropathol (Berl) 59:75–77Google Scholar
  56. 56.
    Weldon-Linne CM, Victor TA, Groothuis DR, Vick NA (1983) Pleomorphic xanthoastrocytoma. Cancer 52:2055–2063Google Scholar
  57. 57.
    Yung WKA, Luna M, Borit A (1985) Vimentin and glial fibrillary acidic protein in human tumors. J Neurooncol 3:35–38Google Scholar
  58. 58.
    Zuccharello M, Sewaya R, Ray MB (1987) Immunohistochemical demonstration of alpha-1-proteinase inhibitor in brain tumors. Cancer 60:804–809Google Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • W. Paulus
    • 1
  • J. Peiffer
    • 1
  1. 1.Institut für HirnforschungUniversität TübingenTübingenFederal Republic of Germany

Personalised recommendations